Terms: = Colorectal cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
32 results:
1. il-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract] [Full Text] [Related]
2. Reigniting hope in cancer treatment: the promise and pitfalls of il-2 and il-2R targeting strategies.
Muhammad S; Fan T; Hai Y; Gao Y; He J
Mol Cancer; 2023 Jul; 22(1):121. PubMed ID: 37516849
[TBL] [Abstract] [Full Text] [Related]
3. Cytokine concentration in peripheral blood of patients with colorectal cancer.
Li W; Chen F; Gao H; Xu Z; Zhou Y; Wang S; Lv Z; Zhang Y; Xu Z; Huo J; Zhao J; Zong Y; Feng W; Shen X; Wu Z; Lu A
Front Immunol; 2023; 14():1175513. PubMed ID: 37063892
[TBL] [Abstract] [Full Text] [Related]
4. Association between oxidative stress, mitochondrial function of peripheral blood mononuclear cells and gastrointestinal cancers.
Liu W; Gao Y; Li H; Wang X; Jin M; Shen Z; Yang D; Zhang X; Wei Z; Chen Z; Li J
J Transl Med; 2023 Feb; 21(1):107. PubMed ID: 36765353
[TBL] [Abstract] [Full Text] [Related]
5. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for colorectal cancer.
Hao T; Yu H; Huang D; Liu Q
Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
[TBL] [Abstract] [Full Text] [Related]
6. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
Front Immunol; 2021; 12():619932. PubMed ID: 33868236
[TBL] [Abstract] [Full Text] [Related]
7. TIGIT promotes CD8
Liang R; Zhu X; Lan T; Ding D; Zheng Z; Chen T; Huang Y; Liu J; Yang X; Shao J; Wei H; Wei B
Cancer Immunol Immunother; 2021 Oct; 70(10):2781-2793. PubMed ID: 33634371
[TBL] [Abstract] [Full Text] [Related]
8. Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer.
Ji D; Zhang D; Zhan T; Jia J; Han W; Li Z; Li M; Song C; Wang J; Gu J
Genomics; 2021 Jan; 113(1 Pt 2):957-966. PubMed ID: 33129922
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
Chen YL; Wang GX; Lin BA; Huang JS
Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Variants of the
Dimberg J; Shamoun L; Landerholm K; Andersson RE; Kolodziej B; Wågsäter D
Anticancer Res; 2019 Sep; 39(9):4933-4940. PubMed ID: 31519598
[TBL] [Abstract] [Full Text] [Related]
11. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).
Prieto-Nieto MI; Pastor D; Rodríguez-Cobos J; Pérez JP; Méndez C; Palacios E; Arranz-Alvarez M; Santos-López J; Cano-Vega M; Viñal D; Rodríguez N; Domínguez G
Clin Transl Oncol; 2019 Oct; 21(10):1432-1439. PubMed ID: 31025168
[TBL] [Abstract] [Full Text] [Related]
12. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.
Krzystek-Korpacka M; Zawadzki M; Kapturkiewicz B; Lewandowska P; Bednarz-Misa I; Gorska S; Witkiewicz W; Gamian A
Cytokine; 2018 Oct; 110():435-441. PubMed ID: 29801973
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic roles for il-2-producing and CD69
Taylor ES; McCall JL; Shen S; Girardin A; Munro FM; Black MA; Ward-Hartstonge KA; Kemp RA
Int J Cancer; 2018 Oct; 143(8):2008-2016. PubMed ID: 29752720
[TBL] [Abstract] [Full Text] [Related]
14. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract] [Full Text] [Related]
15. In Vitro Killing of colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation Status.
Turin I; Delfanti S; Ferulli F; Brugnatelli S; Tanzi M; Maestri M; Cobianchi L; Lisini D; Luinetti O; Paulli M; Perotti C; Todisco E; Pedrazzoli P; Montagna D
J Immunother; 2018 May; 41(4):190-200. PubMed ID: 29293164
[TBL] [Abstract] [Full Text] [Related]
16. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
[TBL] [Abstract] [Full Text] [Related]
18. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism.
Bayhan Z; Simşek T; Ergül E; Utkan NZ; Canturk NZ; Cekmen M
Hepatogastroenterology; 2014 Oct; 61(135):1889-94. PubMed ID: 25713884
[TBL] [Abstract] [Full Text] [Related]
19. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
[TBL] [Abstract] [Full Text] [Related]
20. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
Gao D; Li C; Xie X; Zhao P; Wei X; Sun W; Liu HC; Alexandrou AT; Jones J; Zhao R; Li JJ
PLoS One; 2014; 9(4):e93886. PubMed ID: 24699863
[TBL] [Abstract] [Full Text] [Related]
[Next]
